Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02501044 · ClinicalTrials.gov registry record
Oxygen Desaturation During Hemodialysis
A clinical trial, sponsored by Renal Research Institute.
- Completed
- Registry status
- 5,500
- Enrollment target
NCT02501044: Completed study, sponsored by Renal Research Institute.
NCT02501044 is a clinical trial that has completed, run by Renal Research Institute. The registered enrollment target is 5,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02501044 has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 5,500 participants
- Enrollment target
Study Summary
Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues. The investigators hypothesize that: 1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients. 2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.
Primary Outcome
Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
What the finished NCT02501044 record still lists
NCT02501044 is an observational study that tracks outcomes without assigning an intervention. Its 5,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02501044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02501044 about?
NCT02501044 is a clinical study titled "Oxygen Desaturation During Hemodialysis". Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues. The investigators hypothesize that: 1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of a...
What is the current status of trial NCT02501044?
This trial is currently completed. The enrollment target is 5,500 participants. The study started on 2012-01. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT02501044?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia